Home > Products > CD3 & IGF1R
> Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (CrossMab)
Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (CrossMab) (CAT#: CROSSAB-092)
Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget T cells to tumor cells. It is designed for the research of Melanoma; Colon cancer; Pancreas cancer; Prostate cancer; Kidney cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (CrossMab) (CROSSAB-092). Click the button below to contact us or submit your feedback about this product.